These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10160989)

  • 41. Aerosol drug delivery: developments in device design and clinical use.
    Dolovich MB; Dhand R
    Lancet; 2011 Mar; 377(9770):1032-45. PubMed ID: 21036392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New liquid aerosol generation devices: systems that force pressurized liquids through nozzles.
    Geller DE
    Respir Care; 2002 Dec; 47(12):1392-404; discussion 1404-5. PubMed ID: 12467498
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Managing the transition to CFC-free inhalers.
    Fehrenbach C
    Prof Nurse; 2000 Jan; 15(4):248-50. PubMed ID: 10983140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Basic techniques for aerosol delivery during mechanical ventilation.
    Dhand R
    Respir Care; 2004 Jun; 49(6):611-22. PubMed ID: 15165296
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metering performance of several metered-dose inhalers with different spacers/holding chambers.
    Berlinski A; Waldrep JC
    J Aerosol Med; 2001; 14(4):427-32. PubMed ID: 11791683
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of aerosolized drugs.
    Wolff RK; Niven RW
    J Aerosol Med; 1994; 7(1):89-106. PubMed ID: 10147060
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new method to evaluate plume characteristics of hydrofluoroalkane and chlorofluorocarbon metered dose inhalers.
    Gabrio BJ; Stein SW; Velasquez DJ
    Int J Pharm; 1999 Sep; 186(1):3-12. PubMed ID: 10469919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Availability and consumption status of CFC and non-CFC inhalers for asthma and chronic obstructive pulmonary diseases in Thailand.
    Bunnag C; Vasanavathana S; Punyaratabandhu P
    Asian Pac J Allergy Immunol; 2006; 24(2-3):85-95. PubMed ID: 17136872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measurements of electrodynamic effects on the deposition of MDI and DPI aerosols in a replica cast of human oral-pharyngeal-laryngeal airways.
    Ali M; Mazumder MK; Martonen TB
    J Aerosol Med Pulm Drug Deliv; 2009 Mar; 22(1):35-44. PubMed ID: 18800879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pressurized metered dose inhalers and add-on devices.
    Terzano C
    Pulm Pharmacol Ther; 2001; 14(5):351-66. PubMed ID: 11603949
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novolizer: the new technology for the management of asthma therapy.
    Köhler D
    Curr Opin Pulm Med; 2003 Apr; 9 Suppl 1():S11-6. PubMed ID: 12974537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhalation therapy with metered-dose inhalers and dry powder inhalers in mechanically ventilated patients.
    Dhand R
    Respir Care; 2005 Oct; 50(10):1331-4; discussion 1344-5. PubMed ID: 16185369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The CFC to HFA transition and its impact on pulmonary drug development.
    Leach CL
    Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhalation therapy of the future--how will it change the way we treat asthma?
    Lötvall J
    J Aerosol Med; 2001; 14 Suppl 1():S45-50. PubMed ID: 11424893
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Challenges in changing to non-chlorofluorocarbon inhalers in the treatment of asthma.
    Walley T; Bundred P; Rannard A; Bogg J
    Postgrad Med J; 1999 Dec; 75(890):710-4. PubMed ID: 10567594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in aerosol devices for the delivery of inhaled medications.
    Ari A; Fink JB
    Expert Opin Drug Deliv; 2020 Feb; 17(2):133-144. PubMed ID: 31959028
    [No Abstract]   [Full Text] [Related]  

  • 58. Prescribers' and users' perspective of CFCs: a market research survey.
    Schlaeppi M
    J Aerosol Med; 1995; 8 Suppl 1():S49-52. PubMed ID: 10150496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of international environmental agreements in metered-dose inhaler technology changes.
    Forte R; Dibble C
    J Allergy Clin Immunol; 1999 Dec; 104(6):S217-20. PubMed ID: 10588977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Optimizing the in vitro performance of Respimat.
    Zierenberg B
    J Aerosol Med; 1999; 12 Suppl 1():S19-24. PubMed ID: 10623337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.